Efficacy of 2.5-mg Prasugrel in Elderly or Low-Body-Weight Patients-Reference-Cited by-同舟云学术

Efficacy of 2.5-mg Prasugrel in Elderly or Low-Body-Weight Patients

Published:2018-08-24 Issue:9 Volume:82 Page:2326-2331
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Wakabayashi Shinichi¹,Ariyoshi Noritaka²,Kitahara Hideki¹,Fujii Kenichi¹,Fujimoto Yoshihide¹,Kobayashi Yoshio¹

Affiliation:

1. Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine

2. Department of Personalized Medicine and Preventive Healthcare Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/9/82_CJ-18-0337/_pdf

Reference20 articles.

1. 1. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo controlled trial. Lancet 2005; 366: 1607–1621.

2. 2. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494–502.

3. 3. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002; 288: 2411–2420.

4. 4. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013; 62: 2261–2273.

5. 5. Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, et al. Bleeding and stent thrombosis on P2Y12-inhibitors: Collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 2015; 36: 1762–1771.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study;Cardiovascular Drugs and Therapy;2023-04-25

2. Pseudoxanthoma elasticum resulting in acute coronary syndrome;Journal of Cardiology Cases;2022-10

3. How to Prevent Bleeding Without Increased Risk of Thrombotic Events;Circulation Journal;2021-10-21

4. Increased risk of adverse events in patients with low-on clopidogrel platelet reactivity after percutaneous coronary intervention: A systematic review and meta-analysis;Cardiology Journal;2021-08-02

5. Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention;International Journal of Cardiology;2021-03